Tilray Brands (TLRY) Net Income towards Common Stockholders Growth (3y) (2022 - 2026)
Tilray Brands (TLRY) Net Income towards Common Stockholders Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 33.22% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 2.94% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 4.50% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 26.82% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 66.11% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -17.90% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -30.70% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 253.53% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -109.16% |
| 10 | Tilray Brands | - | - | 54.95 Mn | 72.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 72.37% |
| Nov 30, 2025 | 20.03% |
| Aug 31, 2025 | 26.47% |
| May 31, 2025 | -10.26% |
| Feb 28, 2025 | -157.74% |
| Nov 30, 2024 | -155.66% |
| Aug 31, 2024 | -0.05% |
| May 31, 2024 | -101.79% |
| Feb 29, 2024 | -66.61% |
| Nov 30, 2023 | 19.72% |
| Aug 31, 2023 | -36.96% |
| May 31, 2023 | -132.09% |
| May 31, 2022 | -804.18% |